checkAd

     266  0 Kommentare Acasti Pharma Provides Update on Recent Financing Activities - Seite 3

    Neither NASDAQ, the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

    Acasti Contact:
    Jan D’Alvise
    Chief Executive Officer
    Tel: 450-686-4555
    Email: info@acastipharma.com
    www.acastipharma.com

    Lesen Sie auch

    Investor Contact:
    Crescendo Communications, LLC   
    Tel: 212-671-1020   
    Email: ACST@crescendo-ir.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Acasti Pharma Provides Update on Recent Financing Activities - Seite 3 LAVAL, Québec, Jan. 27, 2021 (GLOBE NEWSWIRE) - As required pursuant to the policies of the TSX Venture Exchange, Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) is providing an update on the use of its “at-the market” …